NCT00408187 Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients Status COMPLETED Phase PHASE3
NCT00407979 Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis Status COMPLETED Phase N/A
NCT00407342 Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis. Status COMPLETED Phase NA
NCT00399906 A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00395941 Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis Status COMPLETED Phase PHASE2
NCT00384098 Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00377325 The Effectiveness of Lower Cyclosporine Doses for Psoriasis Status WITHDRAWN Phase PHASE2
NCT00373516 Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT00372580 Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis Status UNKNOWN Phase N/A
NCT00371163 Molecular and Cellular Characterization of Spongiotic Dermatitis Status COMPLETED Phase N/A
NCT00368654 Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy Status COMPLETED Phase PHASE1/PHASE2
NCT00365625 Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris Status UNKNOWN Phase N/A
NCT00358670 Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563) Status TERMINATED Phase PHASE3
NCT00358384 Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 Status COMPLETED Phase PHASE1
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2/PHASE3
NCT00338143 A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies Status COMPLETED Phase PHASE3
NCT00336973 A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent Status COMPLETED Phase PHASE4